MedPath

Gait, cOgnitiOn & Decline (GOOD)

Conditions
Mild Dementia
Healthy
Moderate Dementia
Mild Cognitive Impairment
Registration Number
NCT02350270
Lead Sponsor
University Hospital, Angers
Brief Summary

The main objective of the GOOD initiative was to determine which spatio-temporal gait parameters and/or combination(s) of spatio-temporal gait parameters best differentiate between cognitively healthy individuals (CHI), patients with mild cognitive impairment (MCI) and those with mild and moderate dementia.

Detailed Description

Gait disorders are frequent in individuals with cognitive disorders. However, the profile of spatio-temporal gait parameters in the different cognitive status in aging (from normal cognition to dementia) has been poorly studied. Determining this profile associated with the severity of cognitive disorders may be helpful to understand the complex interplay between gait and cognitive disorders and, thus, may have important implication for the diagnosis process of patients with and without dementia. For instance, defining a motor phenotype of the severity of cognitive disorders by using quantitative gait measurements could be used to improve the prediction and the diagnosis of dementia.

The investigators hypothesized that, compared to CHI, people with MCI and mild dementia could be characterized by specific phenotypes of spatio-temporal gait parameters measured with the GAITRite® system, and that these profiles could be explained by declines in domain-specific cognitive performance.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2800
Inclusion Criteria
  • Being 60 years old and older
  • Ability to answer questions
Exclusion Criteria
  • Opposition to the use of information collected for research purposes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spatio-temporal gait parametersThis outcome is assessed at inclusion

Spatio-temporal gait parameters were measured at steady state walking using GAITRite®-system.

Secondary Outcome Measures
NameTimeMethod
Clinical assessmentThis outcome is assessed at inclusion

This outcome was assessed by a questionnaire.

Cognitive statusThis outcome is assessed at inclusion

Cognitive status was assessed by cognitive testing.

Trial Locations

Locations (1)

University Hospital

🇫🇷

Angers, France

University Hospital
🇫🇷Angers, France
Olivier Beauchet, MD, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.